[EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR AND NEUROLOGICAL DISEASES<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE MALADIES CARDIOVASCULAIRES OU NEUROLOGIQUES
申请人:KANDULA MAHESH
公开号:WO2013168007A1
公开(公告)日:2013-11-14
The invention relates to the compounds of formula (I), formula (II) and formula (III) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula (I), formula (II) or formula (III) and methods for the treatment of cardiovascular and neurological diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment: of hyperglycemia, insulin resistance, diabetes mellitus, diabetes insipidus, type 1 diabetes, type 2 diabetes, microvascular complications, macrovascular complications, lipid disorders, prediabetes, obesity, arrhythmia, myocardial infarction, stroke, neuropathy, renal complications, hypertriglyceridemia, cardiovascular complications, postprandial hyperglycemia, depression, Alzheimer's disease, Parkinson's disease, Huntington's disease, inflammation, Crohn's disease, inflammatory bowel disease and obesity.
本发明涉及公式(I)、公式(II)和公式(III)化合物或其药物可接受的盐,以及其多晶形、溶剂化物、对映体、立体异构体和水合物。含有公式(I)、公式(II)或公式(III)化合物的有效量的药物组合物,以及用于治疗心血管和神经系统疾病的方法可以制成口服、颊部、直肠、局部、经皮、经黏膜、静脉、肌肉注射、糖浆或注射剂。这样的组合物可以用于治疗:高血糖、胰岛素抵抗、糖尿病、尿崩症、1型糖尿病、2型糖尿病、微血管并发症、大血管并发症、脂质代谢异常、糖尿病前期、肥胖症、心律失常、心肌梗死、中风、神经病变、肾脏并发症、高甘油三酯血症、心血管并发症、餐后高血糖、抑郁症、阿尔茨海默病、帕金森病、亨廷顿病、炎症、克隆病、炎症性肠病和肥胖症。